FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Agnès Chompret

Research Profile

Physiology

Concepts & Ideas

Disorders

Geographic Areas

France

Genes & Molecular Sequences

Chemicals & Drugs

Cyclin-Dependent Kinase Inhibitor p16

Living Beings

Procedures

DNA Mutational Analysis

Co-author Network

Publications

TOP 3
Aurore Allard; Nadia Haddy; Marie-Cécile Le Deley; Carole Rubino; Mathilde Lassalle; Akthar Samsaldin; Eric Quiniou; Agnès Chompret; Dimitri Lefkopoulos; Ibrahima Diallo; Florent de Vathaire
Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
Laurence Brugières; Gaëlle Pierron; Agnès Chompret; Brigitte Bressac-de Paillerets; Federico Di Rocco; Pascale Varlet; Alain Pierre-Kahn; Olivier Caron; jacques grill; Olivier Delattre
Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
Caroline Kannengiesser; Sharon Brookes; Anna Gutierrez del Arroyo; Danielle Pham; Johny Bombled; Michel Barrois; Olivier Mauffret; Marie-Françoise M Avril; Agnès Chompret; Gilbert M Lenoir; Alain Sarasin; Gordon Peters; Brigitte Bressac-de Paillerets
Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Agnès Chompret (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Aurore Allard; Nadia Haddy; Marie-Cécile Le Deley; Carole Rubino; Mathilde Lassalle; Akthar Samsaldin; Eric Quiniou; Agnès Chompret; Dimitri Lefkopoulos; Ibrahima Diallo; Florent de Vathaire
Role of radiation dose in the risk of secondary leukemia after a solid tumor in childhood treated between 1980 and 1999.
International journal of radiation oncology, biology, physics 2010;78(5):1474-82.
2010: Laurence Brugières; Gaëlle Pierron; Agnès Chompret; Brigitte Bressac-de Paillerets; Federico Di Rocco; Pascale Varlet; Alain Pierre-Kahn; Olivier Caron; jacques grill; Olivier Delattre
Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations.
Journal of medical genetics 2010;47(2):142-4.
2009: Caroline Kannengiesser; Sharon Brookes; Anna Gutierrez del Arroyo; Danielle Pham; Johny Bombled; Michel Barrois; Olivier Mauffret; Marie-Françoise M Avril; Agnès Chompret; Gilbert M Lenoir; Alain Sarasin; Gordon Peters; Brigitte Bressac-de Paillerets
Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.
Human mutation 2009;30(4):564-74.
2008: Fabienne LESUEUR; M de Lichy; Michel Barrois; G Durand; Johny Bombled; Marie-Françoise Avril; Agnès Chompret; Françoise Boitier; Gilbert M Lenoir; B Bressac-de Paillerets; Monique Baccard; Bertrand Bachollet; Pascaline Berthet; Valérie Bonadona; Jean-Marie Bonnetblanc; Olivier Caron; Jacqueline Chevrant-Breton; Jean-François Cuny; Stéphane Dalle; Michèle Delaunay; Liliane Demange; Julie De Quatrebarbes; Jean-François Doré; Marc Frénay; Jean-Pierre Fricker; Marion Gauthier-Villars; Paul Gesta; Sophie Giraud; Philippe Gorry; Florent Grange; Andrew Green; Laetitia Huiart; Nicolas Janin; Pascal Joly; Delphine Kérob; Christine Lasset; Dominique Leroux; Jean-Marc Limacher; Michel Longy; Sandrine Mansard; Karine Marrou; Tanguy Martin-Denavit; Christine Mateus; Eve Maubec; Laurence Olivier-Faivre; Vincent Orlandini; Pascal Pujol; Bruno Sassolas; Dominique Stoppa-Lyonnet; Luc Thomas; Pierre Vabres; Laurence Venat; Ewa Wierzbicka; Hélène Zattara
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.
British journal of cancer 2008;99(2):364-70.
2008: Barbara Pasini; Sarah R McWhinney; Thalia Bei; Ludmila Matyakhina; Sotirios Stergiopoulos; michael muchow; Sosipatros Boikos; Barbara Ferrando; Karel Pacak; Guillaume Assie; Eric Baudin; Agnès Chompret; Jay W Ellison; Jean-Jacques Briere; Pierre Rustin; Anne-Paule Gimenez-Roqueplo; Charis Eng; J Aidan Carney; Constantine Straturis
Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.
European journal of human genetics : EJHG 2008;16(1):79-88.
2007: Loïc de Pontual; Delphine Trochet; Franck Bourdeaut; Sophie Thomas; Heather C Etchevers; Agnès Chompret; Véronique Minard; Dominique Valteau; Laurence Brugieres; Arnold Munnich; Olivier Delattre; Stanislas LYONNET; Isabelle Janoueix-Lerosey; Jeanne Amiel
Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
European journal of cancer (Oxford, England : 1990) 2007;43(16):2366-72.
2007: Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernhard RYFFEL; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Nature medicine 2007;13(9):1050-9.
2007: Alisa M Goldstein; Valérie Chaudru; Paola Ghiorzo; Cèlia Badenas; Josep Malvehy; Lorenza Pastorino; Karine Laud; Benjamin Hulley; Marie-Françoise Avril; Joan A Puig-Butille; Annie Miniere; Rosa Marti; Agnès Chompret; Francisco Cuellar; Isabel Kolm; Montserrat Mila; Margaret A Tucker; Florence Demenais; Giovanna Bianchi-Scarra; Susana Puig; Brigitte Bressac de-Paillerets
Cutaneous phenotype and MC1R variants as modifying factors for the development of melanoma in CDKN2A G101W mutation carriers from 4 countries.
International journal of cancer. Journal international du cancer 2007;121(4):825-31.
2007: Caroline Kannengiesser; Stéphane Dalle; Marie-Thérèse Leccia; Marie-Françoise Avril; Valérie Bonadona; Agnès Chompret; Christine Lasset; Dominique Leroux; Luc Thomas; Fabienne LESUEUR; Gilbert Lenoir; Alain Sarasin; Brigitte Bressac De-Paillerets
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatment.
Genes, chromosomes & cancer 2007;46(8):751-60.
2007: Agnès Chompret; Catherine Noguès; Dominique Stoppa-Lyonnet
[Oncogenetic consultation for breast cancer].
Presse médicale (Paris, France : 1983) 2007;36(2 Pt 2):357-63.
2007: Christian Monnerat; Agnès Chompret; Caroline Kannengiesser; Marie-Françoise Avril; Nicolas Janin; Alain Spatz; Jean-Marc Guinebretière; Catalin Marian; Michel Barrois; Françoise Boitier; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma.
Familial cancer 2007;6(4):453-61.
2006: Julien Mancini; Catherine Noguès; Claude Adenis; Pascaline Berthet; Valérie Bonadona; Agnès Chompret; Isabelle Coupier; François Eisinger; Jean-Pierre Fricker; Marion Gauthier-Villars; Christine Lasset; Alain Lortholary; Tan Dat N'Guyen; Philippe Vennin; Hagay Sobol; Dominique Stoppa-Lyonnet; Claire Julian-Reynier
Patients' characteristics and rate of Internet use to obtain cancer information.
Journal of public health (Oxford, England) 2006;28(3):235-7.
2006: Gaëlle Bougeard; Stephanie Baert-Desurmont; Isabelle Tournier; S Vasseur; Cosette Martin; L Brugieres; Agnès Chompret; Brigitte Bressac De-Paillerets; Dominique Stoppa-Lyonnet; C Bonaiti-Pellie; Thierry Frebourg
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.
Journal of medical genetics 2006;43(6):531-3.
2006: Julien Mancini; Catherine Noguès; Claude Adenis; Pascaline Berthet; Valérie Bonadona; Agnès Chompret; Isabelle Coupier; François Eisinger; Jean-Pierre Fricker; Marion Gauthier-Villars; Christine Lasset; Alain Lortholary; Tan Dat N'Guyen; Philippe Vennin; Hagay Sobol; Dominique Stoppa-Lyonnet; Claire Julian-Reynier
Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing.
European journal of cancer (Oxford, England : 1990) 2006;42(7):871-81.
2006: Nadine Andrieu; David E Goldgar; Douglas F Easton; Matti A Rookus; Richard Brohet; Antonis C Antoniou; Susan Peock; Gareth Evans; Diana Eccles; Fiona Douglas; Catherine Noguès; Marion Gauthier-Villars; Agnès Chompret; Flora E van Leeuwen; Irma Kluijt; Javier Benitez; Brita Arver; Edith Olah; Jenny Chang-Claude
Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).
Journal of the National Cancer Institute 2006;98(8):535-44.
2006: C Pruvost-Balland; Philippe Gorry; N Boutet; Thierry Magnaldo; Gérard Mamelle; Alvaro Margulis; Frédéric Kolb; Pierre Duvillard; Alain Spatz; Laurence Brugières; Agnès Chompret; Marie-Françoise Avril
[Clinical and genetic study in 22 patients with basal cell nevus syndrome].
Annales de dermatologie et de vénéréologie 2006;133(2):117-23.
2006: Daniel Satgé; L Honoré; Annie J Sasco; Michel J Vekemans; Agnès Chompret; Marie-Odile Réthoré
An ovarian dysgerminoma in Down syndrome. Hypothesis about the association.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():375-9.
2006: Karine Laud; Catalin Marian; Marie-Françoise Avril; Michel Barrois; Agnès Chompret; Alisa M Goldstein; Margaret A Tucker; P A Clark; G Peters; Valérie Chaudru; Florence Demenais; Alain Spatz; M W Smith; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.
Journal of medical genetics 2006;43(1):39-47.
2005: L Albiges; F André; Corinne Balleyguier; Gonzalo Gomez-Abuin; Agnès Chompret; Suzette Delaloge
Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1846-7.
2005: David J Hughes; Sophie M Ginolhac; Isabelle Coupier; Laure Barjhoux; Valerie Gaborieau; Brigitte Bressac De-Paillerets; Agnès Chompret; Yves-Jean Bignon; Nancy Uhrhammer; Christine Lasset; Sophie Giraud; Hagay Sobol; Agnès Hardouin; Pascaline Berthet; Jean-Philippe Peyrat; Joëlle Fournier; Catherine Nogues; Rosette Lidereau; Danièle Muller; Jean-Pierre Fricker; Michel Longy; Christine Toulas; Rosine Guimbaud; Drakoulis Yannoukakos; Sylvie Mazoyer; Henry T Lynch; Gilbert M Lenoir; David E Goldgar; Dominique Stoppa-Lyonnet; Olga M Sinilnikova
Breast cancer risk in BRCA1 and BRCA2 mutation carriers and polyglutamine repeat length in the AIB1 gene.
International journal of cancer. Journal international du cancer 2005;117(2):230-3.
2005: Valérie Chaudru; Karine Laud; Marie-Françoise Avril; Annie Minière; Agnès Chompret; Brigitte Bressac De-Paillerets; Florence Demenais
Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(10):2384-90.
2004: Isabelle Tournier; Brigitte Bressac-de Paillerets; Hagay Sobol; Dominique Stoppa-Lyonnet; Rosette Lidereau; Michel Barrois; Sylvie Mazoyer; Florence Coulet; Agnès Hardouin; Agnès Chompret; Alain Lortholary; Pierre Chappuis; Violaine Bourdon; Valérie Bonadona; Christine Maugard; Brigitte Gilbert; Catherine Nogues; Thierry Frébourg; Mario Tosi
Significant contribution of germline BRCA2 rearrangements in male breast cancer families.
Cancer research 2004;64(22):8143-7.
2004: Jean Feunteun; Agnès Chompret; Anne Helbling-Leclerc; Dominique Stoppa-Lyonnet; Muriel Belotti; Catherine Noguès; Catherine Bonaïti-Pellié
Sex ratio among the offspring of BRCA mutation carriers.
JAMA : the journal of the American Medical Association 2004;292(6):687-8.
2004: Agnès Chompret; Laurence Brugières; Catherine Bonaïti-Pellié; Jean Feunteun
Sex differences in cancer risk among germline p53 mutation carriers.
British journal of cancer 2004;91(3):603-4.
2004: Valérie Chaudru; Agnès Chompret; Brigitte Bressac De-Paillerets; Alain Spatz; Marie-Françoise Avril; Florence Demenais
Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Journal of the National Cancer Institute 2004;96(10):785-95.
2004: Philippe Morice; Patricia Pautier; Suzette Delaloge; A Spatz; Agnès Chompret
Surgical procedure in patients with ovarian cancer diagnosed at the time of prophylactic oophorectomy. Analysis of two cases, literature review and surgical implications.
European journal of obstetrics, gynecology, and reproductive biology 2004;113(2):251-4.
2004: taraneh shojaei; Agnès Chompret; Anne Abel; Florent de Vathaire; Marie-Anne Raquin; Laurence Brugières; Jean Feunteun; Olivier Hartmann; Catherine Bonaïti-Pellié
Genetic epidemiology of neuroblastoma: a study of 426 cases at the Institut Gustave-Roussy in France.
Pediatric blood & cancer 2004;42(1):99-105.
2004: Agnès Chompret; Caroline Kannengiesser; Michel Barrois; Philippe Terrier; Philippe Dahan; Thomas Tursz; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor.
Gastroenterology 2004;126(1):318-21.
2003: Daniel Satgé; Annie J Sasco; Agnès Chompret; Daniel Orbach; Françoise Méchinaud; Brigitte Lacour; Bernard Roullet; Hélène Martelli; Christophe Bergeron; Yves Bertrand; Didier Lacombe; Yves Perel; Pascal Monteil; Brigitte Nelken; Anne-Isabelle Bertozzi; Martine Munzer; Justine Kanold; Fréderic Bernard; Michel J Vekemans; Danièle Sommelet
A 22-year French experience with solid tumors in children with Down syndrome.
Pediatric hematology and oncology 2003;20(7):517-29.
2003: Karine Laud; Caroline Kannengiesser; Marie-Françoise Avril; Agnès Chompret; Dominique Stoppa-Lyonnet; Laurence Desjardins; Alain Eychene; Florence Demenais; Gilbert M Lenoir; Brigitte Bressac De-Paillerets
BRAF as a melanoma susceptibility candidate gene?
Cancer research 2003;63(12):3061-5.
2003: Agnès Chompret
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Journal de gynécologie, obstétrique et biologie de la reproduction 2003;32(2):101-19.
2003: Emanuel Yakobson; Shlomit Eisenberg; Ruth Isacson; David Halle; Ephrat Levy-Lahad; Raphael Catane; Mark Safro; Vladimir Sobolev; Thomas Huot; Gordon Peters; Anna Ruiz; Josep Malvehy; Suzana Puig; Agnès Chompret; Marie-Fracoise Avril; Raphael Shafir; Hava Peretz; Brigitte Bressac De-Paillerets
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
European journal of human genetics : EJHG 2003;11(4):288-96.
2003: Marie-Cécile Le Deley; Thierry Leblanc; Akthar Shamsaldin; Marie-Anne Raquin; Brigitte Lacour; Danièle Sommelet; Agnès Chompret; Jean-Michel Cayuela; Chantal Bayle; Alain BERNHEIM; Florent de Vathaire; Gilles Vassal; Catherine Hill
Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Société Française d'Oncologie Pédiatrique.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1074-81.
2003: Gaëlle Bougeard; Laurence Brugières; Agnès Chompret; Paul Gesta; Frédéric Charbonnier; Alexander Valent; Cosette Martin; Gregory RAUX; Jean Feunteun; Brigitte Bressac De-Paillerets; Thierry Frébourg
Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene.
Oncogene 2003;22(6):840-6.
2002: D Timothy Bishop; Florence Demenais; Alisa M Goldstein; Wilma Bergman; Julia Newton Bishop; Brigitte Bressac De-Paillerets; Agnès Chompret; Paola Ghiorzo; Nelleke A Gruis; Johan Hansson; Mark Harland; Nicholas Hayward; Elizabeth A Holland; Graham J Mann; Michela Mantelli; Derek Nancarrow; Anton Platz; Margaret A Tucker
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
Journal of the National Cancer Institute 2002;94(12):894-903.
2002: Agnès Chompret
The Li-Fraumeni syndrome.
Biochimie 2002;84(1):75-82.
2002: Brigitte Bressac De-Paillerets; Marie-Françoise Avril; Agnès Chompret; Florence Demenais
Genetic and environmental factors in cutaneous malignant melanoma.
Biochimie 2002;84(1):67-74.
2001: S Auroy; Marie-Françoise Avril; Agnès Chompret; Danielle Pham; Alisa M Goldstein; Giovanna Bianchi-Scarrà; T Frebourg; P Joly; Alain Spatz; C Rubino; Florence Demenais; Brigitte Bressac De-Paillerets
Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.
Genes, chromosomes & cancer 2001;32(3):195-202.
2001: Morice Philippe; P Pautier; Suzette Delaloge; S Camatte; A Spatz; Agnès Chompret; C Lhommé; P Duvillard; D Castaigne
Surgical management for prophylactic oophorectomy in women with an inherited risk of ovarian cancer.
Tumori 2001;87(4):S16-7.
2001: Agnès Chompret
[Genetic diagnosis of cancers? Which cancers should be screened?].
Annales de médecine interne 2001;152(4):249-61.
2001: Thierry Frebourg; Anne Abel; C Bonaiti-Pellie; Laurence Brugières; Pascaline Berthet; Brigitte Bressac De-Paillerets; A Chevrier; Agnès Chompret; O Cohen-Haguenauer; O Delattre; JOSUE FEINGOLD; Jean Feunteun; D Frappaz; J P Fricker; P Gesta; Philippe Jonveaux; Chantal Kalifa; Christine Lasset; Bruno Leheup; Jean-Marc Limacher; Michel Longy; Catherine Nogues; Daniel Oppenheim; Danièle Sommelet; F Soubrier; claude stoll; Dominique Stoppa-Lyonnet; H Tristant
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
Bulletin du cancer 2001;88(6):581-7.
2001: Marie-Françoise Avril; Agnès Chompret; L Verne-Fourment; Marie-José Terrier-Lacombe; Alain Spatz; Karim Fizazi; Brigitte Bressac De-Paillerets; Florence Demenais; Christine Théodore
Association between germ cell tumours, large numbers of naevi, atypical naevi and melanoma.
Melanoma research 2001;11(2):117-22.
2001: Michel Barrois; M K Eychenne; Marie-José Terrier-Lacombe; N Duarte; C Dubourg; Sétha Douc-Rasy; Agnès Chompret; M Khagad; Olivier Hartmann; Daniel Caput; Jean Bénard
Genomic and allelic expression status of the p73 gene in human neuroblastoma.
Medical and pediatric oncology 2001;36(1):45-7.
2001: Agnès Chompret; Anne Abel; Dominique Stoppa-Lyonnet; L Brugiéres; S Pagés; Jean Feunteun; Catherine Bonaïti-Pellié
Sensitivity and predictive value of criteria for p53 germline mutation screening.
Journal of medical genetics 2001;38(1):43-7.
2000: Suzette Delaloge; Morice Philippe; Agnès Chompret; C Lhommé
Prophylactic surgery: oophorectomy or adnexectomy?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3454-5.
2000: Paola Ciotti; Jeffery Struewing; Michela Mantelli; Agnès Chompret; Marie-Françoise Avril; Pier Luigi Santi; Margaret A Tucker; Giovanna Bianchi-Scarrà; Brigitte Bressac De-Paillerets; Alisa M Goldstein
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.
American journal of human genetics 2000;67(2):311-9.
2000: Elizabeth A Rapley; Rita Barfoot; Catherine Bonaïti-Pellié; Agnès Chompret; W Foulkes; N Perusinghe; A Reeve; Brigitte Royer-Pokora; Valerie Schumacher; Andrew N Shelling; J Skeen; S de Tourreil; Angela Weirich; Kathy Pritchard-Jones; Michael R Stratton; Nazneen Rahman
Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
British journal of cancer 2000;83(2):177-83.
2000: Laurent Briollais; Agnès Chompret; Michel Guilloud-Bataille; Brigitte Bressac De-Paillerets; M F Avril; Florence Demenais
Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
International journal of epidemiology 2000;29(3):408-15.
2000: Agnès Chompret; Laurence Brugières; M Ronsin; M Gardes; F Dessarps-Freichey; Anne Abel; D Hua; Laurent Ligot; Marie-Gabrielle Dondon; Brigitte Bressac De-Paillerets; Thierry Frébourg; Jean Lemerle; Catherine Bonaïti-Pellié; Jean Feunteun
P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
British journal of cancer 2000;82(12):1932-7.
1998: Deborah J Marsh; V Coulon; Kathryn L Lunetta; P Rocca-Serra; Patricia Dahia; Z Zheng; D Liaw; S Caron; B Duboué; A Y Lin; Andrea L Richardson; J M Bonnetblanc; J M Bressieux; A Cabarrot-Moreau; Agnès Chompret; L Demange; RA Eeles; A M Yahanda; Eric R Fearon; J P Fricker; RJ Gorlin; Shirley V Hodgson; S Huson; D Lacombe; Charis Eng
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Human molecular genetics 1998;7(3):507-15.
1998: Nadem Soufir; Marie-Françoise Avril; Agnès Chompret; Florence Demenais; Johny Bombled; Alain Spatz; Dominique Stoppa-Lyonnet; Jean Bénard; Brigitte Bressac De-Paillerets
Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
Human molecular genetics 1998;7(2):209-16.
1997: S J Kony; Florent de Vathaire; Agnès Chompret; A Shamsaldim; Emmanuel Grimaud; Marie-Anne Raquin; Odile Oberlin; Laurence Brugières; Jean Feunteun; François Eschwège; Jean Chavaudra; Jean Lemerle; Catherine Bonaïti-Pellié
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood.
Lancet 1997;350(9071):91-5.
1996: C Moutou; C Le Bihan; Agnès Chompret; N Poisson; Laurence Brugières; B Bressac; Jean Feunteun; Jean Lemerle; Catherine Bonaïti-Pellié
Genetic transmission of susceptibility to cancer in families of children with soft tissue sarcomas.
Cancer 1996;78(7):1483-91.
1996: C Le Bihan; C Moutou; Agnès Chompret; A Abel; N Poisson; Laurence Brugières; Jean Lemerle; C Bonaïti-Pelliè
Cancers in relatives of children with non-Hodgkin's lymphoma.
Leukemia research 1996;20(2):181-6.
1996: L Briollais; Agnès Chompret; M Guilloud-Bataille; N Feingold; Marie-Françoise Avril; F Demenais
Genetic and epidemiological risk factors for a malignant melanoma-predisposing phenotype: the great number of nevi.
Genetic epidemiology 1996;13(4):385-402.
1995: Florent Grange; Agnès Chompret; M Guilloud-Bataille; Jean-Claude Guillaume; Alvaro Margulis; M Prade; F Demenais; Marie-Françoise Avril
Comparison between familial and nonfamilial melanoma in France.
Archives of dermatology 1995;131(10):1154-9.
1994: M C Stolzenberg; Laurence Brugières; M Gardes; F Dessarps-Freichey; Agnès Chompret; B Bressac; G Lenoir; Catherine Bonaïti-Pellié; Jean Lemerle; Jean Feunteun
Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family.
Oncogene 1994;9(10):2799-804.
1994: C Moutou; J Hochez; Agnès Chompret; MF Tournade; C Le Bihan; Jean-Michel Zucker; Jean Lemerle; Catherine Bonaïti-Pellié
The French Wilms' tumour study: no clear evidence for cancer prone families.
Journal of medical genetics 1994;31(6):429-34.
1993: Catherine Bonaïti-Pellié; Agnès Chompret; MF Tournade; Jean Lemerle; P A Voute; JF Delemarre
Excess of multifocal tumors in nephroblastoma: implications for mechanisms of tumor development and genetic counseling.
Human genetics 1993;91(4):373-6.
1993: Laurence Brugières; M Gardes; C Moutou; Agnès Chompret; V Meresse; A Martin; N Poisson; Françoise Flamant; Catherine Bonaïti-Pellié; Jean Lemerle
Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
Cancer research 1993;53(3):452-5.
1993: C Moutou; Agnès Chompret; J Hochez; MF Tournade; Jean-Michel Zucker; Jean Lemerle; C Junien; Catherine Bonaïti-Pellié
Testing genomic imprinting in Wilm's tumor.
European journal of human genetics : EJHG 1993;1(3):190-205.
1992: Odile Oberlin; Guy Leverger; Hélène Pacquement; Marie-Anne Raquin; Agnès Chompret; Jean-Louis Habrand; Marie-José Terrier-Lacombe; P Bey; Yves Bertrand; Hervé Rubie
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1602-8.
1992: Catherine Bonaïti-Pellié; Agnès Chompret; MF Tournade; J Hochez; C Moutou; Jean-Michel Zucker; D Steschenko; M Brunat-Mentigny; H Roché; P Tron
Genetics and epidemiology of Wilms' tumor: the French Wilms' tumor study.
Medical and pediatric oncology 1992;20(4):284-91.
1988: Catherine Bonaïti-Pellié; Agnès Chompret; MF Tournade; Jean-Michel Zucker; Jean Lemerle
[A French genetic and epidemiologic study on nephroblastoma: preliminary results].
Bulletin du cancer 1988;75(1):131-3.
1985: JOSUE FEINGOLD; E Bois; Agnès Chompret; M Broyer; M C Gubler; J P Grünfeld
Genetic heterogeneity of Alport syndrome.
Kidney international 1985;27(4):672-7.
1985: E Bois; E Mornet; Agnès Chompret; JOSUE FEINGOLD; J Hochez; V Goulet
[Congenital adrenal hyperplasia (21-OH) in France. Population genetics].
Archives françaises de pédiatrie 1985;42(3):175-9.